The clinical impact of 131-iodine whole-body scintigraphy following 131-iodine therapy of thyroid cancer
Open Access
- 18 August 2026
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 86 (6) , 694-701
Abstract
The incidence of thyroid cancer has increased globally in recent years, primarily due to a more widespread use of imaging particularly in terms of ultrasonography and subsequent biopsies [1]. The a...Keywords
This publication has 12 references indexed in Scilit:
- 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid CancerThyroid®, 2025
- Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA: A Cancer Journal for Clinicians, 2024
- The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinomaJournal of Cancer Research and Clinical Oncology, 2024
- Determining the appropriate time of execution of an I-131 post-therapy whole-body scanNuclear Medicine Communications, 2013
- Value of 131I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literatureEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scansEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Post I-131 Therapy Scanning in Patients With Thyroid Carcinoma Metastases: An Unnecessary Cost or a Relevant Contribution?Clinical Nuclear Medicine, 2004
- Problems in dealing with missing data and informative censoring in clinical trialsCurrent Controlled Trials in Cardiovascular Medicine, 2002
- Superiority of Iodine-123 Compared with Iodine-131 Scanning for Thyroid Remnants in Patients with Differentiated Thyroid CancerClinical Nuclear Medicine, 2001
- Are Posttherapy Radioiodine Scans Informative and Do They Influence Subsequent Therapy of Patients with Differentiated Thyroid Cancer?Thyroid®, 2000